Cencora (0HF3) Share Forecast & Price Target
0HF3 Analyst Ratings
Strong Buy
11Buy3Hold0Sell
Based on 14 analysts giving stock ratings to Cencora in the past 3 months
0HF3 Stock 12 Month Forecast
Average Price Target
$373.08▲(12.38% Upside)Based on 14 Wall Street analysts offering 12 month price targets for Cencora in the last 3 months. The average price target is $373.08 with a high forecast of $400.00 and a low forecast of $330.00. The average price target represents a 12.38% change from the last price of $331.98.
Past 12 Months12 Month ForecastDec2025Sep2026
High$400.00
Average$373.08
Low$330.00
Highest Price TargetHighest$400.00Average Price Target$373.08Lowest Price TargetLowest$330.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Erin Wright | Morgan Stanley | $346→$377 | buy | 13.56%Upside | Assigned | 10/30/26 | ||
| Eric Coldwell | Robert W. Baird | $373→$375 | buy | 12.96%Upside | Reiterated | 10/22/26 | ||
| Allen Lutz | Bank of America Securities | $330→$345 | hold | 3.92%Upside | Reiterated | 10/21/26 | ||
| David Toung | Argus Research | $340→$380 | buy | 14.46%Upside | Reiterated | 10/20/26 | ||
| Kevin Caliendo | UBS | $430→$400 | buy | 20.49%Upside | Reiterated | 10/16/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | $380→$388 | buy | 16.87%Upside | Reiterated | 10/07/26 | ||
| Ryan Halsted | RBC Capital | $330 | hold | -0.60%Downside | Reiterated | 10/06/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | $350 | buy | 5.43%Upside | Reiterated | 08/13/26 | ||
| Glen Santangelo | Barclays | $350 | buy | 5.43%Upside | Reiterated | 08/13/26 | ||
| Stephen Baxter | Wells Fargo | $331→$395 | buy | 18.98%Upside | Assigned | 08/11/26 | ||
| Lisa Gill | J.P. Morgan | $390 | buy | 17.48%Upside | Reiterated | 08/10/26 | ||
| Charles Rhyee | TD Cowen | $400 | buy | 20.49%Upside | Reiterated | 08/09/26 | ||
| Daniel Grosslight | Citi | $355→$370 | buy | 11.45%Upside | Reiterated | 08/06/26 | ||
| Ryan Daniels | William Blair | ― | hold | ― | Reiterated | 08/05/26 | ||
| Brian Tanquilut | Jefferies | $330→$440 | buy | 32.54%Upside | Upgraded | 01/22/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Erin Wright | 10/30/26 | $346→$377 | buy | 13.56%Upside | Assigned | Morgan Stanley | ||
| Eric Coldwell | 10/22/26 | $373→$375 | buy | 12.96%Upside | Reiterated | Robert W. Baird | ||
| Allen Lutz | 10/21/26 | $330→$345 | hold | 3.92%Upside | Reiterated | Bank of America Securities | ||
| David Toung | 10/20/26 | $340→$380 | buy | 14.46%Upside | Reiterated | Argus Research | ||
| Kevin Caliendo | 10/16/26 | $430→$400 | buy | 20.49%Upside | Reiterated | UBS | ||
| Unknown AnalystNot Ranked | 10/07/26 | $380→$388 | buy | 16.87%Upside | Reiterated | Leerink Partners | ||
| Ryan Halsted | 10/06/26 | $330 | hold | -0.60%Downside | Reiterated | RBC Capital | ||
| Elizabeth Anderson CFA | 08/13/26 | $350 | buy | 5.43%Upside | Reiterated | Evercore ISI | ||
| Glen Santangelo | 08/13/26 | $350 | buy | 5.43%Upside | Reiterated | Barclays | ||
| Stephen Baxter | 08/11/26 | $331→$395 | buy | 18.98%Upside | Assigned | Wells Fargo | ||
| Lisa Gill | 08/10/26 | $390 | buy | 17.48%Upside | Reiterated | J.P. Morgan | ||
| Charles Rhyee | 08/09/26 | $400 | buy | 20.49%Upside | Reiterated | TD Cowen | ||
| Daniel Grosslight | 08/06/26 | $355→$370 | buy | 11.45%Upside | Reiterated | Citi | ||
| Ryan Daniels | 08/05/26 | ― | hold | ― | Reiterated | William Blair | ||
| Brian Tanquilut | 01/22/26 | $330→$440 | buy | 32.54%Upside | Upgraded | Jefferies |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cencora
3 Months
Success Rate27/39 ratings generated profit
69%
Average Return
+5.49%
Copying Charles Rhyee's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +5.49% per trade.
1 Year
Success Rate41/48 ratings generated profit
85%
Average Return
+22.06%
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 85.42% of your transactions generating a profit, with an average return of +22.06% per trade.
2 Years
Success Rate36/39 ratings generated profit
92%
Average Return
+37.17%
Copying Charles Rhyee's trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +37.17% per trade.
0HF3 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 1 | 0 | 0 |
| Buy | 12 | 9 | 12 | 11 | 16 |
| Hold | 6 | 8 | 8 | 8 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 21 | 21 | 19 | 23 |
In the current month, 0HF3 has received 16 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. 0HF3 average Analyst price target in the past 3 months is 373.08.
0HF3 Financial Forecast
High$4.62
Consensus$4.58
Low$4.53
0HF3 Earnings Forecast
Next quarter’s earnings estimate for 0HF3 is $4.58 with a range of $4.53 to $4.62. The previous quarter’s EPS was $4.48. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$88.7B
Consensus$88B
Low$86.7B
0HF3 Sales Forecast
Next quarter’s sales forecast for 0HF3 is $87.95B with a range of $86.70B to $88.72B. The previous quarter’s sales results were $84.75B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
0HF3 Stock Forecast FAQ
What is GB:0HF3’s average 12-month price target, according to analysts?
Based on analyst ratings, Cencora’s 12-month average price target is $373.08.
What is GB:0HF3’s upside potential, based on the analysts’ average price target?
Cencora has 12.38% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cencora a Buy, Sell or Hold?
Cencora has a consensus rating of Strong Buy, which is based on 11 buy ratings, 3 hold ratings and 0 sell ratings.
What is Cencora’s share price target?
The average share price target for Cencora is $373.08. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $400.00, and the lowest forecast is $330.00. The average share price target represents a 12.38% increase from the current price of $331.98.
What do analysts say about Cencora?
Cencora’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Cencora?
To buy shares of GB:0HF3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
